Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis.

Armstrong AW, Warren RB, Sofen H, Spelman L, Linaberry M, Becker B, Jou YM, Daamen C, Kimball AB.

DOI: 10.1007/s13555-025-01606-9
Published: 2025-12-05
Container: Dermatol Ther (Heidelb)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13555-025-01606-9,
  title = {Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis.},
  author = {Armstrong AW and  Warren RB and  Sofen H and  Spelman L and  Linaberry M and  Becker B and  Jou YM and  Daamen C and  Kimball AB.},
  year = {2026},
  journal = {Dermatol Ther (Heidelb)},
  doi = {10.1007/s13555-025-01606-9},
  url = {https://doi.org/10.1007/s13555-025-01606-9}
}

RIS

TY  - JOUR
TI  - Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis.
AU  - Armstrong AW
AU  -  Warren RB
AU  -  Sofen H
AU  -  Spelman L
AU  -  Linaberry M
AU  -  Becker B
AU  -  Jou YM
AU  -  Daamen C
AU  -  Kimball AB.
PY  - 2026
JO  - Dermatol Ther (Heidelb)
DO  - 10.1007/s13555-025-01606-9
UR  - https://doi.org/10.1007/s13555-025-01606-9
ER  -

APA

AW, A., RB, W., H, S., L, S., M, L., B, B., YM, J., C, D., & AB., K. (2026). Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis.. Dermatol Ther (Heidelb). https://doi.org/10.1007/s13555-025-01606-9

Source records

europe-pmc · retrieved 2026-09-25T06:34:07.576Z